Sunday - December 22, 2024

Measurement of 2-Hydroxyglutarate Enantiomer Levels as a Biomarker for IDH Mutant Cancers

2024-12-17

ALEXANDRIA, Virginia, Dec. 17 -- BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, Austin, Texas has been assigned a patent (No. US 12169202 B2, initially filed Feb. 10, 2021) developed by three inventors Mark R. Emmett, Galveston, Texas; Shinji K. Strain, Texas City, Texas; and Morris D. Groves, West Lake Hills, Texas, for "Measurement of 2-hydroxyglutarate enantiomer levels as a biomarker for IDH mutant cancers." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Measurement of 2-Hydroxyglutarate Enantiomer Levels as a Biomarker for IDH Mutant Cancers

Information Request Form

Copyright Targeted News Service 2024